Rmb Capital Management, LLC Caribou Biosciences, Inc. Transaction History

Rmb Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.62 - $5.05 $98,342 - $306,560	60,705 Added 65.09%	153,964 $252,000
Q1 2024 May 14, 2024	BUY	$4.82 - $8.26 $81,501 - $139,668	16,909 Added 22.15%	93,259 $479,000
Q3 2023 Nov 13, 2023	BUY	$4.08 - $8.14 $7,021 - $14,008	1,721 Added 2.31%	76,350 $364,000
Q1 2023 May 11, 2023	BUY	$4.3 - $7.78 $94,002 - $170,078	21,861 Added 41.43%	74,629 $396,000
Q4 2022 Feb 14, 2023	SELL	$5.57 - $11.01 $122,645 - $242,429	-22,019 Reduced 29.44%	52,768 $331,000
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $399,362 - $956,525	74,787 New	74,787 $789,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $114M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.